4-[5-(4-aminophenyl)-1,3,4-oxadiazol-2-yl]aniline structure
|
Common Name | 4-[5-(4-aminophenyl)-1,3,4-oxadiazol-2-yl]aniline | ||
|---|---|---|---|---|
| CAS Number | 2425-95-8 | Molecular Weight | 252.27100 | |
| Density | 1.301g/cm3 | Boiling Point | 508.1ºC at 760mmHg | |
| Molecular Formula | C14H12N4O | Melting Point | 250-254 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 261.1ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | 4-[5-(4-aminophenyl)-1,3,4-oxadiazol-2-yl]aniline |
|---|---|
| Synonym | More Synonyms |
| Density | 1.301g/cm3 |
|---|---|
| Boiling Point | 508.1ºC at 760mmHg |
| Melting Point | 250-254 °C(lit.) |
| Molecular Formula | C14H12N4O |
| Molecular Weight | 252.27100 |
| Flash Point | 261.1ºC |
| Exact Mass | 252.10100 |
| PSA | 90.96000 |
| LogP | 3.73040 |
| Vapour Pressure | 1.91E-10mmHg at 25°C |
| Index of Refraction | 1.669 |
| InChIKey | MJZXFMSIHMJQBW-UHFFFAOYSA-N |
| SMILES | Nc1ccc(-c2nnc(-c3ccc(N)cc3)o2)cc1 |
| Storage condition | −20°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2934999090 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Sensitization of group III and IV muscle afferents in the mouse after ischemia and reperfusion injury.
J. Pain 15(12) , 1257-70, (2015) Ischemic myalgia is a unique type of muscle pain in the patient population. The role that discrete muscle afferent subpopulations play in the generation of pain during ischemic events, however, has ye... |
|
|
Sensitive and Selective Determination of Orotic Acid in Biological Specimens Using a Novel Fluorogenic Reaction.
J. Fluoresc. 25 , 1005-11, (2015) Orotic acid is an intermediate in the synthesis pathway of uridine-5'-monophosphate, and increases in body fluids of patients suffering from hereditary disorders such as orotic aciduria and hyperammon... |
|
|
Cytofluorometric determination of nuclear DNA in living and preserved algae.
Stain Technol. 57(5) , 273-82, (1982) Three DNA-localizing fluorochromes used in conjunction with epi (incident) UV illumination were examined for sensitivity and selectivity for the cytofluorometric determination of nuclear DNA in ten sp... |
|
Name: Primary cell-based high-throughput screening assay for identification of compounds th...
Source: Johns Hopkins Ion Channel Center
Target: regulator of G-protein signaling 4 isoform 2 [Homo sapiens]
External Id: JHICC_RGS_Act_HTS
|
|
Name: Luminescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id: OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
Name: QFRET-based biochemical primary high throughput screening assay to identify exosite i...
Source: The Scripps Research Institute Molecular Screening Center
Target: disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id: ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
Name: uHTS identification of small molecule activators of the adaptive arm of the Unfolded ...
Source: Burnham Center for Chemical Genomics
Target: N/A
External Id: BCCG-A405-UPR-XBP1-PrimaryAgonist-Assay
|
|
Name: A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS979
|
|
Name: Fluorescence polarization to screen for inhibitor that competite the binding of FadD2...
Source: Broad Institute
Target: FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE)
External Id: 2147-01_Inhibitor_SinglePoint_HTS_Activity
|
|
Name: Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfect...
Source: Broad Institute
Target: N/A
External Id: Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition - 7011-01_Antagonist_SinglePoint_HTS_Activity
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify pos...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
Name: Fluorescence polarization-based biochemical high throughput primary assay to identify...
Source: The Scripps Research Institute Molecular Screening Center
Target: RecName: Full=Sialate O-acetylesterase; AltName: Full=H-Lse; AltName: Full=Sialic acid-specific 9-O-acetylesterase; Flags: Precursor [Homo sapiens]
External Id: SIAE_INH_FP_1536_1X%INH PRUN
|
| 2-(n-aminophenyl)-5-(n-aminophenyl)-1,3,4-oxadiazole |
| 2,5-BIS(4-AMINOPHENYL)-1,3,4-OXADIAZOLE |
| 2,5-bis(4-aminophenylene)-1,3,4-oxadiazole |
| EINECS 219-373-8 |
| 2,5-bis(p-aminophenyl)-1,3,4-oxadiazole |
| 4,4'-(1,3,4-Oxadiazole-2,5-diyl)dianiline |
| 2,5-Bis-(4-aminophenyl)-1,3,4-oxadiazole |
| 2,5-bis(4-aminobenzoyl)-1,3,4-oxadiazole |
| MFCD00042667 |